The U.S. Attorney's Office for the Southern District of New York subpoenaed Bristol-Myers Squibb in an investigation of the company's marketing practices for antipsychotic Abilify, according to a company filing with the Securities and Exchange Commission.
Bristol receives subpoena over Abilify marketing
SmartBrief Job Listings for Health Care
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|
|Director Account Management||
Samaritan Health Services
|Hospital Medical Device Sales||
Linda Hertz Group